Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVACC-B: HBV Vaccination in Indolent Lymphoproliferative Disorders
NCT01698866Phase 4Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Jul 2012
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
A Phase 4 trial of GenHevac-B in hepatitis B (HBV), sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.
02
Drugs
GenHevac-B
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01698866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01698866.